The latest biotech news

News and Trends 2 Nov 2022

Enzyre secures €12M series A funding to help hemophilia patients test from home

Dutch company, Enzyre, which is developing ambulant diagnostic technology for blood coagulation testing, today (November 2) announced it has successfully raised €12 million ($11.9 million) in series A financing. The round was led by new investor, Oost NL, with participation from i&i Biotech Fund, Demcon Investment as technology partner and existing investors, Takeda Ventures and […]

November 2, 2022 - 3 minutesmins - By Liza Laws

News and Trends 2 Nov 2022

Could DNA nanotransporters treat cancer?

A team of Canadian researchers from Université de Montréal has designed and validated a new class of drug transporters made of DNA 20,000 times smaller than a human hair. The DNA nanotransporters could improve how cancers and other diseases are treated. Reported in a new study in Nature Communications, the molecular transporters can be chemically […]

November 2, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

Avista Capital Partners acquires Taconic Biosciences

Private equity company Avista Capital Partners has acquired Taconic Biosciences, a provider of genetically engineered research models (GEMs) and related services, from H.I.G. Capital. Transaction terms were not disclosed. Founded in 1952 and headquartered in Rensselaer, N.Y., Taconic Biosciences specializes in genetically engineered research models and services, specifically murine models for use in drug discovery […]

November 1, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

Proscia presents results on AI melanoma diagnostic predictions

Proscia has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer. The findings, presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance. Conducted at […]

November 1, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

J.P. Morgan launches life sciences private capital team

J.P. Morgan Asset Management has announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team will invest in early and growth stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas. These include genetic […]

November 1, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

First to market doesn’t guarantee success

A comparison of two cancer drugs, Opdivo and Keytruda, reveals that being the first-to-market is not necessarily the main factor in a drug’s success. For the first four years since their approval, the anticancer drug Opdivo outperformed Keytruda in sales. But this trend reversed in 2018, with Keytruda’s sales becoming higher than Opdivo’s. Recently, a […]

November 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

Citeline and Norstella merge to create $5B pharma technology company

Norstella has announced the completion of its merger with Citeline (formerly Pharma Intelligence). Upon closing, the $5 billion global company is now one of the world’s largest pharma intelligence solutions providers on the market, with more than 1,600 employees across the five brands that make up Norstella: Evaluate, MMIT, Panalgo, The Dedham Group, and now […]

November 1, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

Pancreatic cancer could be diagnosed years earlier

Pancreatic cancer could be identified in patients up to three years earlier than current diagnoses, new research from the U.K. shows. Weight loss and increasing blood glucose levels are early indicators of pancreatic cancer and could lead to a more timely diagnosis, helping to improve survival rates. In the largest study of its kind, researchers […]

November 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

Tetris Pharma launches hypoglycemia injector pen in Germany

Tetris Pharma Ltd, a subsidiary of biopharma company Arecor Therapeutics plc, has launched Ogluo (glucagon prefilled autoinjector pen) in Germany as a treatment for severe hypoglycemia in children and adults living with diabetes. Ogluo is a ready-to-use, ambiently stored, preparation of glucagon that has been specifically designed for patients living with diabetes with severe hypoglycemia. […]

November 1, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 1 Nov 2022

Human Immunology Biosciences launches with $120M

Human Immunology Biosciences (HI-Bio), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), announced its launch with $120 million in financing. HI-Bio was incubated by ARCH Venture Partners and Monograph Capital, joined by Jeito Capital and unnamed institutional investors and family offices. Few targeted therapies exist for the autoimmune, allergic […]

November 1, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 31 Oct 2022

First patient enrolled and dosed on expansion phase of cancer treatment trial

The first patient in an expansion phase of a trial looking at cancer drug Modi-1 has been enrolled and dosed. Scancell Holdings plc, the developer of immunotherapies for the treatment of cancer and infectious disease made the announcement today (October 31). The expansion phase is part of the monotherapy arms of the phase 1 clinical […]

October 31, 2022 - 3 minutesmins - By Liza Laws

News and Trends 31 Oct 2022

Researchers develop efficient nanovaccine delivery system boosting cellular immunity

A research group has successfully developed a new nanovaccine delivery system, to strongly activate cellular immunity, using one-tenth of the amount of antigen that was previously required. Led by Eiji Yuba, an associate professor at the Graduate School of Engineering at Osaka Metropolitan University in Japan, the group has been developing been developing the […]

October 31, 2022 - 3 minutesmins - By Liza Laws

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Enzyre secures €12M series A funding to help hemophilia patients test from home

Could DNA nanotransporters treat cancer?

Avista Capital Partners acquires Taconic Biosciences

Proscia presents results on AI melanoma diagnostic predictions

J.P. Morgan launches life sciences private capital team

First to market doesn’t guarantee success

Citeline and Norstella merge to create $5B pharma technology company

Pancreatic cancer could be diagnosed years earlier

Tetris Pharma launches hypoglycemia injector pen in Germany

Human Immunology Biosciences launches with $120M

First patient enrolled and dosed on expansion phase of cancer treatment trial

Researchers develop efficient nanovaccine delivery system boosting cellular immunity

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!